Literature DB >> 32245530

Pharmacologic Management of Hepatic Encephalopathy.

Noah Y Mahpour1, Lauren Pioppo-Phelan1, Mishal Reja1, Augustine Tawadros1, Vinod K Rustgi2.   

Abstract

Pharmacologic management of hepatic encephalopathy includes a broad range of therapies. This article covers the specific mainstays of therapies, such as antimicrobials and laxatives, with an established evidence base. This article also covers newer modalities of therapies, such as fecal microbiota transplant, probiotics, bioartificial support systems, small molecular therapies such as l-ornithine l-aspartate, branched chain amino acids, l-carnitine, zinc, and other forms of therapy currently under review.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acarbose; Branched chain amino acid; FMT; Lactulose; Ornithine phenylacetate; Zinc; l-carnitine; l-ornithine l-aspartate

Mesh:

Substances:

Year:  2020        PMID: 32245530     DOI: 10.1016/j.cld.2020.01.005

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  1 in total

Review 1.  Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Authors:  Jiachen Liu; Yantao Xu; Bimei Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.